State Street’s HUTCHMED HCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.56M Sell
304,829
-16,476
-5% -$241K ﹤0.01% 2995
2025
Q4
$4.28M Buy
321,305
+3,801
+1% +$55.5K ﹤0.01% 3060
2025
Q3
$5M Sell
317,504
-11,288
-3% -$186K ﹤0.01% 2995
2025
Q2
$4.95M Sell
328,792
-8,073
-2% -$118K ﹤0.01% 2947
2025
Q1
$5.07M Sell
336,865
-10,738
-3% -$159K ﹤0.01% 2879
2024
Q4
$5.01M Sell
347,603
-1,921
-0.5% -$34.3K ﹤0.01% 2977
2024
Q3
$6.83M Buy
349,524
+3,078
+0.9% +$55.7K ﹤0.01% 2811
2024
Q2
$5.93M Buy
346,446
+2,792
+0.8% +$51.5K ﹤0.01% 2841
2024
Q1
$5.77M Sell
343,654
-5,116
-1% -$77.6K ﹤0.01% 2865
2023
Q4
$6.32M Sell
348,770
-44,185
-11% -$803K ﹤0.01% 2843
2023
Q3
$6.66M Sell
392,955
-41,301
-10% -$592K ﹤0.01% 2793
2023
Q2
$5.21M Sell
434,256
-46,700
-10% -$637K ﹤0.01% 2973
2023
Q1
$6.26M Sell
480,956
-22,028
-4% -$361K ﹤0.01% 2904
2022
Q4
$7.43M Sell
502,984
-687,930
-58% -$7.52M ﹤0.01% 2861
2022
Q3
$10.6M Buy
1,190,914
+11,417
+1% +$144K ﹤0.01% 2679
2022
Q2
$14.9M Sell
1,179,497
-33,563
-3% -$427K ﹤0.01% 2448
2022
Q1
$23M Sell
1,213,060
-52,229
-4% -$1.33M ﹤0.01% 2293
2021
Q4
$44.4M Buy
1,265,289
+74,715
+6% +$2.43M ﹤0.01% 1891
2021
Q3
$43.6M Buy
1,190,574
+66,385
+6% +$2.61M ﹤0.01% 1903
2021
Q2
$44.1M Buy
1,124,189
+40,243
+4% +$1.16M ﹤0.01% 1937
2021
Q1
$30.6M Buy
1,083,946
+15,739
+1% +$502K ﹤0.01% 2088
2020
Q4
$34.2M Sell
1,068,207
-31,670
-3% -$974K ﹤0.01% 1891
2020
Q3
$35.5M Buy
1,099,877
+34,903
+3% +$1.09M ﹤0.01% 1689
2020
Q2
$29.4M Buy
1,064,974
+4,085
+0.4% +$88.6K ﹤0.01% 1804
2020
Q1
$18.9M Buy
1,060,889
+38,500
+4% +$929K ﹤0.01% 1874
2019
Q4
$25.6M Buy
1,022,389
+29,916
+3% +$655K ﹤0.01% 1971
2019
Q3
$17.7M Buy
992,473
+91,230
+10% +$1.9M ﹤0.01% 2132
2019
Q2
$19.8M Buy
901,243
+58,468
+7% +$1.67M ﹤0.01% 2111
2019
Q1
$25.8M Buy
842,775
+89,832
+12% +$2.24M ﹤0.01% 1882
2018
Q4
$17.4M Buy
+752,943
New +$23.4M ﹤0.01% 2088

Other funds holding HCM

State Street's HCM Position: Q1 2026 in Review

State Street reduced its HUTCHMED (HCM) stake by 5.1% in Q1 2026, selling an estimated $241K and leaving 304,829 shares worth $4.56M. The position accounts for ﹤0.01% of the portfolio, ranked #2995.

State Street first reported a position in HCM in Q4 2018 and has held it in 30 quarters since. The position peaked at $44.4M in Q4 2021. 54 funds tracked by Wall St. Rank hold HCM as of Q1 2026.

  • State Street held 304,829 shares of HUTCHMED worth $4.56M as of Q1 2026.
  • State Street sold 16,476 HUTCHMED shares in Q1 2026, an estimated $241K.
  • HUTCHMED made up ﹤0.01% of State Street's portfolio in Q1 2026, its #2995 holding.
  • State Street first reported a position in HUTCHMED in Q4 2018 and has held it in 30 quarters since.
  • State Street's HUTCHMED position peaked at $44.4M in Q4 2021.
  • 54 funds tracked by Wall St. Rank held HUTCHMED as of Q1 2026.

Based on State Street's 13F filing for Q1 2026, filed 15 May 2026.